1. Home
  2. STAA vs MSDL Comparison

STAA vs MSDL Comparison

Compare STAA & MSDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STAA
  • MSDL
  • Stock Information
  • Founded
  • STAA 1982
  • MSDL 2019
  • Country
  • STAA United States
  • MSDL United States
  • Employees
  • STAA N/A
  • MSDL N/A
  • Industry
  • STAA Ophthalmic Goods
  • MSDL
  • Sector
  • STAA Health Care
  • MSDL
  • Exchange
  • STAA Nasdaq
  • MSDL NYSE
  • Market Cap
  • STAA 850.9M
  • MSDL 1.7B
  • IPO Year
  • STAA N/A
  • MSDL N/A
  • Fundamental
  • Price
  • STAA $17.29
  • MSDL $19.42
  • Analyst Decision
  • STAA Hold
  • MSDL Hold
  • Analyst Count
  • STAA 8
  • MSDL 5
  • Target Price
  • STAA $27.17
  • MSDL $20.00
  • AVG Volume (30 Days)
  • STAA 743.0K
  • MSDL 416.2K
  • Earning Date
  • STAA 08-06-2025
  • MSDL 01-01-0001
  • Dividend Yield
  • STAA N/A
  • MSDL 11.43%
  • EPS Growth
  • STAA N/A
  • MSDL N/A
  • EPS
  • STAA N/A
  • MSDL N/A
  • Revenue
  • STAA $279,134,000.00
  • MSDL N/A
  • Revenue This Year
  • STAA N/A
  • MSDL $1,597.39
  • Revenue Next Year
  • STAA $27.83
  • MSDL $15.10
  • P/E Ratio
  • STAA N/A
  • MSDL N/A
  • Revenue Growth
  • STAA N/A
  • MSDL N/A
  • 52 Week Low
  • STAA $13.50
  • MSDL $17.59
  • 52 Week High
  • STAA $46.79
  • MSDL $23.62
  • Technical
  • Relative Strength Index (RSI)
  • STAA 51.94
  • MSDL 53.83
  • Support Level
  • STAA $17.11
  • MSDL $18.84
  • Resistance Level
  • STAA $18.00
  • MSDL $19.49
  • Average True Range (ATR)
  • STAA 0.65
  • MSDL 0.26
  • MACD
  • STAA 0.10
  • MSDL 0.05
  • Stochastic Oscillator
  • STAA 69.57
  • MSDL 89.41

About STAA STAAR Surgical Company

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.

About MSDL MORGAN STANLEY DIRECT LENDING FUND

Morgan Stanley Direct Lending Fund is a fund whose investment objective is to achieve attractive risk-adjusted returns via current income and to a lesser extent, capital appreciation by investing predominantly in directly originated senior secured term loans issued by U.S. middle-market companies backed by private equity sponsors. It invests predominantly in directly originated senior secured term loans including first lien senior secured term loans including unitranche loans and second lien senior secured term loans, with the balance of the investments expected to be in higher-yielding assets such as mezzanine debt, unsecured debt, equity investments and other opportunistic asset purchases.

Share on Social Networks: